Laminar Growth of US $19,379.2 Mn to Be Witnessed by Erythropoietin Drugs Market by 2025 End
According to the research report, the global erythropoietin drugs market is expected to be worth US$19,379.2 mn by the end of 2025 as it surges at CAGR of 7.5% from 2017 to 2025. Out of the various applications of erythropoietin drugs, cancer is expected to be the highest revenue contributor.
View full press release